Literature DB >> 2345065

Fluorinated anthracyclines: synthesis and biological activity.

K C Tonkin1, R T Brownlee, F Zunino, D R Phillips.   

Abstract

A number of fluorine containing derivatives of daunomycin and Adriamycin have been synthesised with a fluorine substituent located on the C-9 side chain. They included the p-trifluoromethyl-(4) and p-fluorobenzoate (3) esters of Adriamycin and the trifluoro-ethyl-hydrazones of Adriamycin (2) and daunomycin (1). The less polar derivatives (esters 3 and 4) appear to enter HeLa cells more readily than the polar derivatives (hydrazones 1 and 2) as indicated by the rates and extent of cellular uptake and the uptake was by facilitated diffusion. All four fluorinated derivatives were less active than their parent anthracyclines, but the difference was less pronounced when considering specific potency. The fluorinated derivatives (1-4) behave sufficiently similar to daunomycin and Adriamycin to enable their use as fluorine probes in 19F NMR physicochemical and cellular studies of anthracyclines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345065     DOI: 10.1007/bf00216918

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  11 in total

1.  Commentary. The role of structure-activity studies in the design of antitumor agents.

Authors:  B F Cain
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

2.  Cellular pharmocodynamics of several anthrocycline antibiotics.

Authors:  N R Bachur; M Steele; W D Meriwether; R C Hildebrand
Journal:  J Med Chem       Date:  1976-05       Impact factor: 7.446

3.  "Aromatic" substituent constants for structure-activity correlations.

Authors:  C Hansch; A Leo; S H Unger; K H Kim; D Nikaitani; E J Lien
Journal:  J Med Chem       Date:  1973-11       Impact factor: 7.446

4.  Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin.

Authors:  F Arcamone; G Franceschi; A Minghetti; S Penco; S Redaelli
Journal:  J Med Chem       Date:  1974-03       Impact factor: 7.446

5.  Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions.

Authors:  K Yamamoto; E M Acton; D W Henry
Journal:  J Med Chem       Date:  1972-08       Impact factor: 7.446

6.  Biologic properties of three anthracyclines as a function of lipophilicity.

Authors:  D Kessel
Journal:  Biochem Pharmacol       Date:  1979-10-01       Impact factor: 5.858

Review 7.  Intercalating drugs: DNA binding and molecular pharmacology.

Authors:  W D Wilson; R L Jones
Journal:  Adv Pharmacol Chemother       Date:  1981

8.  Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.

Authors:  A Goldin; J M Venditti; J S Macdonald; F M Muggia; J E Henney; V T Devita
Journal:  Eur J Cancer       Date:  1981-02       Impact factor: 9.162

9.  [Study of the experimental anti-tumor action of a new semi-synthetic antibiotic: rubidazone (22 050 R. P.)].

Authors:  R Maral; G Ponsinet; G Jollès
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1972-07-10

Review 10.  Model systems for cardiotoxic effects of anthracyclines.

Authors:  G Zbinden; E Bachmann; C Holderegger
Journal:  Antibiot Chemother (1971)       Date:  1978
View more
  1 in total

1.  Fluorinated anthracyclines: interactions with DNA.

Authors:  K C Tonkin; R C Boston; R T Brownlee; D R Phillips
Journal:  Invest New Drugs       Date:  1990-11       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.